Search

everythinglearnresearchcommunity

for

Search:↓

Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.

Women with hair loss have weaker hair that breaks more easily.

Iron deficiency is a common nutritional cause of hair loss.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Female pattern hair loss in women is caused by hormones and genetics, leading to hair thinning, with various treatments available.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Laser-assisted drug delivery improves hair loss.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Turkish women with female pattern hair loss have lower hair density, and visual counting is more effective than digital image analysis for detecting this.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Tick bites can cause hair loss similar to alopecia areata, and baricitinib may help regrow hair.

Rogaine can stop hair loss in women, and other treatments like certain pills, light therapy, and special shampoos may also work.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Male pattern hair loss is common, affects mental health, and can be treated with medication or hair transplants.

Low iron levels are common but not directly linked to hair loss in women.

12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.

Zinc levels are not directly linked to pattern hair loss.

5% Azelaic acid is as effective as 2% Minoxidil for female pattern hair loss and could be an alternative for those allergic to Minoxidil or pregnant.

Diffuse hair loss in women is often linked to thyroid problems.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

The man's occipital hair loss was due to temporal triangular alopecia, not alopecia areata.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

Topical minoxidil is the primary treatment for female pattern hair loss in India.

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

The hair growth solution reduced hair loss and increased hair thickness in a small group of patients.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

A woman had temporary hair loss due to stress from a spinal cord injury.